Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report released on Thursday. The firm issued a hold rating on the specialty pharmaceutical company’s stock. PRTK has been the subject of a number of other reports. HC Wainwright reissued a neutral rating and set a $2.15 price objective on […]

Related Keywords

Randallb Brenner ,Williamm Haskel , ,Paratek Pharmaceuticals Trading ,Hunting Hill Global Capital ,Paratek Pharmaceuticals Inc ,Paratek Pharmaceuticals ,Securities Exchange Commission ,Institutional Trading Of Paratek Pharmaceuticals ,News Ratings For Paratek Pharmaceuticals Daily ,Carlyle Group Inc ,Millennium Management ,Polar Asset Management Partners Inc ,Jefferies Financial Group ,Free Report ,Financial Group ,Exchange Commission ,General Counsel William ,Asset Management Partners ,Hill Global Capital ,Get Free Report ,Paratek Pharmaceuticals Daily ,Nasdaq Prtk ,Prtk ,Medical ,89354m10 ,Initiated Coverage ,Stocknews Com ,